ECLEVAR is proud to be selected as part of the UK government's efforts to become a global leader in innovation and high-growth industries.
ECLEVAR is proud to announce that we have been granted the Crédit impôt recherche (CIR), aimed at providing up to a 30% benefit for our clients.
We are thrilled to announce with great pride that ECLEVAR is now part of the "Jeunes Entreprises Innovantes" (Young Innovative Companies)
Streamline your clinical trial process with our comprehensive platform
Orchestrate your Medical device clinical trial with MILO
The MILO Medical device clinical trial Suites are created to engage the patient and improve the speed and agility of clinical research. MILO products are cloud-based solutions designed to improve the clinical trial process and are interoperable with legacy systems. When used together, they power complete orchestration of your trials.
Give your trial the best chance of success
Medtech Clinical trial Site selection using Eclevar is data-first strategy to validate your assumptions and make the right decisions throughout the clinical trial feasibility process—from clinical trial study planning and clinical protocol design to country and site scenario planning and site selection.
Unleashing the Power of Integration
in Clinical Trials
The Eclevar medtech Orchestrated Clinical Trials seamlessly integrates best of breed, modular, interoperable technologies proven to optimize efficiency and enhance clinical trial outcomes.
MEDICAL DEVICE CRO FROM PREMARKET TO POST MARKET CLINICAL FOLLOW-UP (PMCF)
ECLEVAR MEDTECH is a unique CRO, it brings Competent Authority, notified body, industry and CRO expertise together to overcome your clinical evaluation (CER) , clinical trials and regulatory challenges.
New Whitepaper by BSI and Eclevar on EU MDR – Download Now!
We’re thrilled to announce that Eclevar has collaborated with BSI
5 Reasons GI CROs Boost Crohn’s Clinical Trial Success
The prevalence of Crohn’s Disease (CD) is on the rise,
MDCG Sounds The Alarm over lack of MDR, IVDR applications
The European Commission’s Medical Device Coordination Group (MDCG) is alerting
ECLEVAR’s Participation as an Exhibitor at PVI 2023
We are thrilled to announce our participation as an exhibitor at
BALANCES REGULATORY, CLINICAL EVALUATION, AND BUSINESS RISKS AND OBJECTIVES
Competent authorities around the world exchanges information’s about your products risk and efficacy who put your business on stake. ECLEVAR MEDTECH can see your challenges from different angles for better support and understanding. From clinical reports to clinical data collection.
With an international team that encompass: Former Competent Authority/notified body experts, Clinical Evaluation and PMCF experts from the industry, Medical device CRO experts, Key opinions leader for better understanding of your products
If you want know more, Get In touch with OUR Global Chief commercial OFFICER:
Within 3 years, ECLEVAR delivered transformative solutions.
OUR MEDICAL DEVICE PARTNERS AND ASSOCIATIONS
A Regulators Perspective on Clinical Evaluations and Investigations
- A regulator’s thought on the new clinical evaluation requirements – does it solve the problem?
- What are the key challenges for the regulator in implementing the new requirements?
- The UK – a regulator with ‘two halves’. What are the implications for the UK, and what happens in 2023
Our latest pictures and video
